Analyst Activity – Oppenheimer Reiterates Buy on Recro Pharma (NASDAQ:REPH) (NASDAQ:REPH)

ME Staff
-
0

Analyst Ratings For Recro Pharma (NASDAQ:REPH) (NASDAQ:REPH)

Today, Oppenheimer reiterated its Buy rating on Recro Pharma (NASDAQ:REPH) (NASDAQ:REPH).

Some recent analyst ratings include

  • 3/23/2018-Oppenheimer Reiterated Rating of Buy.
  • 2/14/2018-CIBC initiated coverage with a Outperform rating.
  • 10/27/2017-Piper Jaffray Companies Reiterated Rating of Buy.
  • 6/14/2017-Janney Montgomery Scott was Downgraded by analysts at Janney Montgomery Scott from a “Buy ” rating to a ” Fair Value” rating. They now have a $6.50 price target on the stock, up previously from $21.00 .
  • 3/27/2017-Aegis Reiterated Rating of Buy.
  • 11/29/2016-HC Wainwright Reiterated Rating of Buy.

Recent Insider Trading Activity For Recro Pharma (NASDAQ:REPH) (NASDAQ:REPH)
Recro Pharma (NASDAQ:REPH) (NASDAQ:REPH) has insider ownership of 21.60% and institutional ownership of 57.85%.

  • On 3/13/2018 Healthcare Master Fun Broadfin, Major Shareholder, sold 200,000 with an average share price of $10.07 per share and the total transaction amounting to $2,014,000.00.
  • On 1/3/2018 Scp Vitalife Partners (Israel), Major Shareholder, sold 12,964 with an average share price of $8.88 per share and the total transaction amounting to $115,120.32.
  • On 12/29/2017 Scp Vitalife Partners Ii Lp, Major Shareholder, sold 18,231 with an average share price of $9.27 per share and the total transaction amounting to $169,001.37.
  • On 12/28/2017 Scp Vitalife Partners (Israel), Major Shareholder, sold 1,980 with an average share price of $9.44 per share and the total transaction amounting to $18,691.20.
  • On 12/27/2017 Scp Vitalife Partners Ii Lp, Major Shareholder, sold 13,189 with an average share price of $9.56 per share and the total transaction amounting to $126,086.84.
  • On 12/21/2017 Healthcare Master Fun Broadfin, Major Shareholder, sold 76,000 with an average share price of $9.87 per share and the total transaction amounting to $750,120.00.
  • On 12/13/2017 Healthcare Master Fun Broadfin, Major Shareholder, sold 93,237 with an average share price of $9.86 per share and the total transaction amounting to $919,316.82.

Recent Trading Activity for Recro Pharma (NASDAQ:REPH) (NASDAQ:REPH)
Shares of Recro Pharma (NASDAQ:REPH) closed the previous trading session at 11.12 up +0.05 0.45% with 11.390000343322754 shares trading hands.